Truadvice, LLC Bristol Myers Squibb CO Transaction History

Truadvice, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $632,290 - $740,646	-10,686 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$61.91 - $67.42 $84,507 - $92,028	1,365 Added 14.64%	10,686 $721,000
Q1 2021 Apr 30, 2021	SELL	$59.34 - $66.74 $105,565 - $118,730	-1,779 Reduced 16.03%	9,321 $586,000
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $122,120 - $138,384	2,115 Added 23.54%	11,100 $688,000
Q3 2020 Oct 22, 2020	BUY	$57.43 - $63.64 $516,008 - $571,805	8,985 New	8,985 $543,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Truadvice, LLC, based on Form 13F filings with the SEC.

Stay updated on Truadvice, LLC with notifications on news.